Fulgent Genetics, Inc.
FLGTNasdaqCIK 1674930HealthcareFiscal year ends Dec 31
Reports and events: 142 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-3016:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-326136 |
| 2026-07-3016:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-326119 |
| 2026-06-0219:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001674930-26-000028 |
| 2026-05-2719:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001302110-26-000020 |
| 2026-05-2117:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001674930-26-000025 |
| 2026-05-1416:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-224147 |
| 2026-05-0107:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-199065 |
| 2026-05-0107:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-199061 |
| 2026-03-3116:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001302110-26-000013 |
| 2026-03-3116:11 ET | DEF 14A | Proxy statementPeriod 2026-03-31 | 0001674930-26-000020 |
| 2026-03-1716:36 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001674930-26-000012 |
| 2026-02-2707:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-079169 |
| 2026-02-2707:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-079152 |
| 2025-12-2216:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-328747 |
| 2025-11-0707:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-271013 |
| 2025-11-0707:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271006 |
| 2025-10-2006:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242917 |
| 2025-08-0107:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-101105 |
| 2025-08-0107:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-101103 |
| 2025-05-1516:17 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-072676 |
| 2025-05-0207:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-062258 |
| 2025-05-0207:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-062257 |
| 2025-03-2516:17 ET | DEF 14A | Proxy statementPeriod 2025-03-25 | 0000950170-25-044407 |
| 2025-02-2807:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029512 |
| 2025-02-2807:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-029510 |
| 2024-11-0807:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123684 |
| 2024-11-0807:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123681 |
| 2024-11-0516:46 ET | SC 13D/A | Ownership report, active investor, amended | 0000950170-24-121578 |
| 2024-08-0207:38 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089592 |
| 2024-08-0207:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-089587 |
| 2024-05-1616:29 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-061120 |
| 2024-05-0307:34 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052485 |
| 2024-05-0307:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052481 |
| 2024-03-2716:05 ET | DEF 14A | Proxy statementPeriod 2024-03-27 | 0000950170-24-037159 |
| 2024-02-2817:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022233 |
| 2024-02-2807:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021645 |
| 2023-11-0307:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058512 |
| 2023-11-0307:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-058509 |
| 2023-08-0407:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038316 |
| 2023-08-0407:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-038312 |
| 2023-05-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-023014 |
| 2023-05-0507:24 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-018079 |
| 2023-05-0507:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-018076 |
| 2023-03-3116:10 ET | DEF 14A | Proxy statement | 0000950170-23-011376 |
| 2023-02-2816:49 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-005178 |
| 2023-02-2816:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-005124 |
| 2023-01-1216:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-23-000716 |
| 2023-01-0316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-000048 |
| 2022-11-2316:09 ET | 8-K | 3.01 Delisting notice | 0000950170-22-025666 |
| 2022-11-1021:38 ET | SC 13D/A | Ownership report, active investor, amended | 0001564590-22-037265 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.